The Three Major Components of the Gut Microbiome and the Application of Sequencing Technologies

With a massive and different bacterial community consisting of bacteria, archaea, viruses, and eukaryotic microbes, the human body resides in symbiosis. The microbiome fills up many human organs and tissues, where the gastrointestinal tract (GIT) resides the majority of the human microbiome.

The structure of the gut microbiome can be regarded as a complicated character, with a great many hosts and environmental factors influencing the quantitative variance in the microbiome, each of which can have only a small additional effect, making it hard to recognize the connection for each specific specimen. Many microorganisms seen in the GIT seem to have their specific role, either positive or negative. In this article, we will see how bacteria, fungus, and viruses interact with the human body and how to use sequencing technologies to study them, respectively.

The Bacteria Reside in the GIT

The Gut Microbiome

One of the biggest interfaces (250–400 m^2) between the host, environmental variables, and antigens in the human body is the human gastrointestinal (GI) tract. About 60 massive amounts of food pass through the human GI tract in an average lifetime, along with an abundant supply of environmental microorganisms that cause a massive danger to the integrity of the gut. The 'gut microbiota' compilation of bacteria, archaea, and eukarya colonizing the GI tract is called and has co-evolved over thousands of years with the host to shape a complex and mutually valuable relationship. It has been approximated that the number of microorganisms populating the GI tract exceeds 1014, which includes about 10 times more microbial cells than the number of human cells and over 100 times the genomic material (microbiome) of the human genome. A newly updated approximation, conversely, has recommended that the human: bacterial cell proportion is closer to 1:1. As an outcome of the massive amount of bacterial cells in the body, it is often regarded as a 'super organism' by the host and the microorganisms infesting it.

Sequencing Method for Gut Microbiome

As an indicator and contributor to human health, the increasing knowledge of human gut microbiota implies that it will perform an essential part in the diagnosis, medication, and ultimately avoidance of human illness. Such implementations involve a comprehension of the microbiota's mechanics and reliability over a person's life span. Amplicon sequencing from fecal microbial communities (microbiota) of the bacterial 16S rRNA gene has indicated that a distinct compilation of species is present in each individual. The estimates of the number of species existing in the microbiota of a person have differed widely. Culture-based methods imply ~100 such species, while ~160 such species are indicated by culture-independent deep shotgun sequencing of stool community DNA. The outcomes of 16S rRNA amplicon sequencing recommend many times these figures of species, even after tries in silico to erase chimeric molecules created throughout a polymerase chain reaction (PCR) and errors presented during sequencing. By increasing the series of strains in each specimen with false positives, these objects exacerbate monitoring of specific bacterial taxa over time. Another method to describe variety is shotgun sequencing of the microbiome of the community, but it is complicated to align gene sequences with their genome of beginnings.

Bacterial Composition of Gut

Depending on the research, the percentage of cultivable bacteria in the human gut varied from 15 percent to 85 percent, with more than 1,200 bacterial species described. This environment consists of four main phyla: the most common are the Firmicutes and Bacteroidetes and, to a smaller extent, Actinobacteria and Proteobacteria. Although a universal microbial core containing 66 molecular species, preserved by more than 50% of a population, has been defined, the adult stool microbiota proportion is particular to each individual. The single dominant gut microbiota is fairly steady over time in the lack of disturbances (antibiotics, pathogens, etc.).

The proportion of the intestinal microbiota is heavily dynamic in this early step. Optional anaerobic bacteria, in particular Escherichia coli and other Enterobacteriaceae, have been noted to be the first infant gut colonizers to decrease oxygen, thus maintaining the typical strict anaerobic conditions during the first days of life in the intestinal lumen. The colonialism of purely anaerobic bacteria such as Clostridium, Bacteroides, Bifidobacteria, and rarely Ruminococcus will begin once the anaerobic gut environment is formed, resulting in a highly complex and dynamic bacterial community that can be regarded by about 3 years of age as the healthy adult microbiota.

The spatial procession of the creation of microbiota is quite well established, while it is hard to eliminate the various factors affecting and ultimately establishing the structure. The primordial function of the microbiota of the mother in early colonization is emphasized by its high rate of similarity at 1 month of age. Surprisingly, along with the looks of other environments, this resemblance lessens. The primary extrinsic variables affecting early infant microbiota development are gestation time, type of delivery, and feeding of the infant. Acute prematurity has been associated with enhanced colonization of Staphylococcus. There is a higher presence of Lactobacillus and Prevotella in vaginally born infants, whereas infants supplied by cesarean section have a greater percentage of Staphylococcus, Corynebacterium, and Propionibacterium in their microbiota, highlighting vaginal versus skin microbiota visibility as the primary origin of bacteria.

From early on, diet is a key factor. For example, breastfeeding encourages the presence of bifidobacteria and lactobacilli through the particular formulation of the milk of the mother. Moreover, growing findings imply that breast milk contains a vast array of early human intestinal colonizers such as Staphylococcus, Streptococcus, Propionibacterium, Bifidobacterium, Veillonella, Bacteroides, Clostridium, Enterobacteria, and Roseburia in its own microbiota. This synchronous neonatal gut bacterial colonization looks to be an essential duration for the growth of a microbiota that is varied, flexible, adaptable, and structurally effective.

The Fungus Reside in the GIT

Introduction to Gut Mycobiome

In our ecosystem, fungi are ubiquitous and are defined to be involved in natural and industrial mechanisms, including the development of antibiotics, bread, cheese, and alcoholic drinks; the decomposition of natural debris; and the provision of nutrients to soil plants. Of the world's approximately 5.1 million various species of fungi, only around 300 regularly induce illness in humans. These fairly few fungi are accountable for thousands of illnesses each year, ranging from superficial skin and nail infections to invasive lung, blood, and brain infections. It is not shocking, even so, that fungi are also discovered on and in our bodies as components of the human microbiome, given the high occurrence of fungi in the ecosystem.

One significant part of the human microbiome is the fungal microbiome, classified as the mycobiome. Even though mycobiota makes up a small percentage of the whole human microbiome, researchers have been able to start to reveal the identity of our fungal commensals and evaluate their importance in human wellbeing and illness by culture-independent techniques using high-throughput sequencing methods.

Research on Gut Mycobiome

In the guts of numerous mammals, such as humans, mice, rats, pigs, and many ruminant and non-ruminant herbivores, fungi have been identified. C57BL/6 mice stool characterization showed that more than 97% of fungal sequences came from only 10 fungal species, classifying the amplest commensal fungi as Candida tropicalis and Saccharomyces cerevisiae. In humans, soon after birth, fungi have been discovered to populate the gut. In a research project evaluating dietary correlations between archaea and fungi, participants had an abundant supply of Candida and Saccharomyces species in their stools, with a high abundance of Candida linked with recent carbohydrate intake. In numerous human illnesses, such as inflammatory bowel illness, graft versus host disease, Hirschsprung-associated enterocolitis, colorectal cancer, and developed progression of hepatitis B virus diseases, fungi have been involved in the alleviation. The verified existence of fungi as part of the human microbiome, and their possible role as contributors to health and disease, illustrate the requirements for a more profound characterization of the healthy human microbiome. Understanding a healthy mycobiome will help classify disease-contributing fungal organisms in studies and better identify health-important fungal bacterial relationships.

Human Gut Mycobiome

The Human Microbiome Project (HMP) was one of the immediate objectives of characterizing the "healthy" human microbiome as a basis for reference and comparison experiments. Microbial populations were primarily composed of bacteria from the Bacteroidetes and Firmicutes phyla in HMP healthy donor fecal samples but differed widely between participants. Although in the HMP donor stool, core operational taxonomic units (OTUs) were defined, the relative abundance of these core OTUs were reported to differ almost 5000-fold. This indicates that among people, what qualifies as a healthy gut microbiome can be very distinct. However, in early HMP research, the mycobiome has not been evaluated.

The amplest fungal genus was reported to be Saccharomyces in healthy human stools, preceded by Malassezia and Candida. In at least one specimen from nearly every participant in this research, these three genera were evident, even though the mycobiome was heavily dynamic within and between individuals. The 18S rRNA gene sequencing shows similar outcomes to the ITS2 sequencing, but included the inclusion of Blastocystis as a notable eukaryotic member of the gut microbiome, a non-fungal microbial eukaryote (microeukaryote). In relation, fungi recognized from HMP fecal specimens in metagenomic sequences agreed with the findings of ITS2 sequencing; but, deeper metagenomic sequencing is probably needed to completely assess the intestinal fungal components.?

Research on Gut Mycobiome

In comparison to bacterial microbiomes, experiments displaying the affiliation of the gut fungal microbiome with diseases are lesser, which may be accredited to the numerous struggles that are faced in classifying fungal communities right from extraction of genomic DNA to molecular recognition, the latter primarily because of the existence of high sequence length variance in fungal sequences and to the inconsistent accessibility of datasets of fungal reference sequences. Despite these difficulties, fungal microbiome dysbiosis has been involved in several intestinal illnesses, such as colorectal adenomas, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS), as well as in several other infections, such as myalgic encephalomyelitis/chronic fatigue syndrome, diabetes, and cirrhosis.

A couple of experiments have shown greater immune sensitivity to UVT fungal antigens, suggesting that these fungal antigens may be a significant risk factor for idiopathic UVT, particularly those linked with multiple sclerosis and spondyloarthritis. In relation, a scientist failed to distinguish the antigenic replicate that stimulates UVT in the spontaneous UVT mice model, thus suggesting that the trigger for UVT can be identified by other bacterial diversity, such as fungi.??Therefore, in UVT patients, it is worth investigating the fungal microbiome. The current research intends to describe healthy control (HC) gut fungal microbiomes and UVT participants from a South Indian group to determine whether gut fungal communities are modified in UVT participants and whether UVT is correlated with dysbiosis in gut fungal communities, which may enable to establish new treatment regimens for UVT diagnosis.

The Viruses Reside in the GIT

Introduction to Gut Virome

There are approximately 10^31 viral particles on earth, and at least 10^9 virus-like particles per gram are contained in human stool. Most of these are recognizable as bacteria (bacteriophages) infecting viruses, but the large percentage remains unknown. Even nowadays, mainly novel viruses are still produced by intestinal virus specimens obtained from various human individuals, and only a tiny proportion of viral ORFs represent recently studied genes. Due to their capabilities to transfer genes to their bacterial hosts, bacteriophages are of biomedical significance, thus gaining enhanced pathogenicity, antibiotic susceptibility, and probably new metabolic potential. The forces that broaden bacteriophage genomes in human hosts have not been analyzed in detail, given their relevance. Humans show significant individual variations in the bacterial lineages existing in their guts; one reason for the variations in their phage predators is likely to be this variance. The significant variation between individuals in phage populations can also be affected by individual viral evolution.

Research on Gut Virome

Bacteriophages, which are known to contribute an essential part in shaping microbial diversity through predation and horizontal gene transfer, influence the viral element of the microbiome (the virome). In our understanding of the human microbiome and the elements that influence its structure, these intricate phage populations portray one of the biggest gaps. In existing reference datasets, up to 90 percent of virome sequences convey little to no homology, and viral genomes lack universal marker genes that could assist in their taxonomic task. Many virome research is focused on database-dependent methods that restrict a small fraction of viral sequences that can be defined to the context of the research. Typically, the remainder of viral DNA is ignored and is usually referred to as "viral dark matter ".

The presence of a healthy core gut virome populated by temperate bacteriophages has been proposed, and a connection between the concentration of viromes and bacteriomes has been emphasized. In an amount of gastrointestinal and systemic abnormalities, like inflammatory bowel disease, AIDS, diabetes, and malnutrition, a percentage of cross-sectional population studies have noted disease-specific changes in the intestinal virus. Even so, in the absence of information on the taxonomic status, host range, and biological characteristics of the majority of variably abundant bacteriophage groups, a constructive characterization of these distinctions in the viral composition is unfeasible. It is also important to better understand both the short- and long-term complexities of the structure of viromes at different taxonomic levels.

Many areas of science, such as molecular virology, have been redefined by the invention of massive parallel sequencing, also called next-generation sequencing (NGS). The implementation of NGS in virology, however, is difficult because no sequence signature similar to all viruses is available. The activation of a process that affects B-cells and contributes to type 1 diabetes has been correlated with certain virus infections, but the overall involvement of viruses has remained unanswered.

Identified Viral Groups in Human Gut

Recovery of Microviridae, Podoviridae, Myoviridae, and Siphoviridae was implied by taxonomic assessment of these continues, but contiguous taxonomic identifications were a fringe group, only 13 percent, highlighting the immense variance in sequence present in bacteriophages. Microviridae (including the Φ X174 group) proliferated, but this predominance could be due to the preferred amplification of the small circular genomes that define this group by Φ 29 polymerase. There were no contiguous viruses capable of infecting eukaryotic cells. In one time period, thirty-two percent coverage was noticed for Gyrovirus, and pooling reads over all time points produced 42 percent coverage. Gyrovirus is a genus of circovirus previously published to infiltrate humans with very small genome sizes (about 2.3 kb).

REFERENCES:

1.????Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC. en Leibel, RL (2013)‘The long-term stability of the human gut microbiota’. Science.;341.

2.????Mondot S, de Wouters T, Doré J, Lepage P. The human gut microbiome and its dysfunctions. Digestive Diseases. 2013;31(3-4):278-85.

3.????Thursby E, Juge N. Introduction to the human gut microbiota. Biochemical Journal. 2017 Jun 1;474(11):1823-36.

4.????Kalyana Chakravarthy S, Jayasudha R, Ranjith K, Dutta A, Pinna NK, Mande SS, Sharma S, Garg P, Murthy SI, Shivaji S. Alterations in the gut bacterial microbiome in fungal Keratitis patients. PLoS One. 2018 Jun 22;13(6):e0199640.

5.????Hoffmann C, Dollive S, Grunberg S, Chen J, Li H, Wu GD, Lewis JD, Bushman FD. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PloS one. 2013 Jun 17;8(6):e66019.

6.????Nash AK, Auchtung TA, Wong MC, Smith DP, Gesell JR, Ross MC, Stewart CJ, Metcalf GA, Muzny DM, Gibbs RA, Ajami NJ. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome 5: 153.

7.????Kramná L, Kolá?ová K, Oikarinen S, Pursiheimo JP, Ilonen J, Simell O, Knip M, Veijola R, Hy?ty H, Cinek O. Gut virome sequencing in children with early islet autoimmunity. Diabetes care. 2015 May 1;38(5):930-3.

8.????Minot S, Bryson A, Chehoud C, Wu GD, Lewis JD, Bushman FD. Rapid evolution of the human gut virome. Proceedings of the National Academy of Sciences. 2013 Jul 23;110(30):12450-5.

9.????Shkoporov AN, Clooney AG, Sutton TD, Ryan FJ, Daly KM, Nolan JA, McDonnell SA, Khokhlova EV, Draper LA, Forde A, Guerin E. The human gut virome is highly diverse, stable, and individual specific. Cell host & microbe. 2019 Oct 9;26(4):527-41.